LLY

1,058.52

+2.3%↑

JNJ

233.75

+2.08%↑

ABBV

218.03

+2.36%↑

UNH

388.26

+1.41%↑

AZN

187.06

-0.15%↓

LLY

1,058.52

+2.3%↑

JNJ

233.75

+2.08%↑

ABBV

218.03

+2.36%↑

UNH

388.26

+1.41%↑

AZN

187.06

-0.15%↓

LLY

1,058.52

+2.3%↑

JNJ

233.75

+2.08%↑

ABBV

218.03

+2.36%↑

UNH

388.26

+1.41%↑

AZN

187.06

-0.15%↓

LLY

1,058.52

+2.3%↑

JNJ

233.75

+2.08%↑

ABBV

218.03

+2.36%↑

UNH

388.26

+1.41%↑

AZN

187.06

-0.15%↓

LLY

1,058.52

+2.3%↑

JNJ

233.75

+2.08%↑

ABBV

218.03

+2.36%↑

UNH

388.26

+1.41%↑

AZN

187.06

-0.15%↓

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Open

BrancheGesundheitswesen

21.45 -0.23

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

21.45

Max

21.45

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-3.8M -23M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.68
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

148 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

6.26 / 7.47 Unterstützung & Widerstand

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Mai 2026, 22:48 UTC

Akquisitionen, Fusionen, Übernahmen

Conduent to Sell Public Transit Business to Modaxo for $164 Million

21. Mai 2026, 16:49 UTC

Ergebnisse

Walmart's Fuel Business Benefits from Rising U.S. Gas Prices, Though Volume Per Transaction Falls -- OPIS

21. Mai 2026, 16:26 UTC

Wichtige Markttreiber

Spotify Technology Shares Up Amid New AI Tool For Remixing Songs

21. Mai 2026, 23:51 UTC

Market Talk

Nikkei Might Rise on Continued Hopes for Possible U.S.-Iran Deal -- Market Talk

21. Mai 2026, 23:37 UTC

Ergebnisse

Lenovo Group 4Q Oper Profit $886.0M Vs. $331.0M >0992.HK

21. Mai 2026, 23:37 UTC

Ergebnisse

Lenovo Group 4Q Rev $21.60B Vs. $16.98B >0992.HK

21. Mai 2026, 23:37 UTC

Ergebnisse

Lenovo Group 4Q Net $521.0M Vs. Net $90.0M >0992.HK

21. Mai 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Mixed Sentiment -- Market Talk

21. Mai 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

21. Mai 2026, 23:30 UTC

Market Talk

Napier Port Loses Bull Despite Robust 1H Result -- Market Talk

21. Mai 2026, 22:33 UTC

Akquisitionen, Fusionen, Übernahmen

Conduent to Sell Public Transit Business to Modaxo for $164M

21. Mai 2026, 21:53 UTC

Ergebnisse

Marvell Stock Notches Its 15th Record Closing High This Year -- Barrons.com

21. Mai 2026, 21:02 UTC

Ergebnisse

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, Nebius, Bloom Energy, Applied Digital, Intuit, D-Wave, Spotify, and More -- Barrons.com

21. Mai 2026, 20:55 UTC

Ergebnisse

Walmart Sales Rise as It Navigates Higher Fuel Prices -- 2nd Update

21. Mai 2026, 20:30 UTC

Heiße Aktien

Stocks to Watch Recap: Nvidia, Spotify, Stellantis, Intuit -- WSJ

21. Mai 2026, 20:20 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Mai 2026, 20:20 UTC

Market Talk

Mexico's Revised 1Q GDP Seen Confirming Contraction -- Market Talk

21. Mai 2026, 20:20 UTC

Ergebnisse

Webull 1Q Adj EPS 3c >BULL

21. Mai 2026, 20:20 UTC

Ergebnisse

Webull 1Q Rev $159.9M >BULL

21. Mai 2026, 20:18 UTC

Market Talk

Mexico's Inflation Seen Easing in Early May -- Market Talk

21. Mai 2026, 20:18 UTC

Ergebnisse

Webull 1Q Loss/Shr 4c

21. Mai 2026, 19:43 UTC

Market Talk

Oil Futures Lose Ground on Hopes for U.S.-Iran Deal -- Market Talk

21. Mai 2026, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Edge Up in Steady Trading -- Market Talk

21. Mai 2026, 18:58 UTC

Ergebnisse

Nvidia Is Now the Megacap Cash Machine, and Big Tech Is Footing the Bill -- Barrons.com

21. Mai 2026, 18:15 UTC

Market Talk

Gold Higher For Second Consecutive Day -- Market Talk

21. Mai 2026, 17:40 UTC

Market Talk

Prolonged War Putting Energy Normalcy Further Away -- Market Talk

21. Mai 2026, 17:04 UTC

Market Talk

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21. Mai 2026, 17:01 UTC

Ergebnisse

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, GlobalFoundries, Nebius, Applied Digital, Intuit, Spotify, and More -- Barrons.com

21. Mai 2026, 16:20 UTC

Market Talk

Ergebnisse

Stellantis Targets Distant but Constructive -- Market Talk

21. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

6.26 / 7.47Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Stimmung

By Acuity

148 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.